CClinicalTrials.gg
CompletedNCT07191301Updated Mar 5, 2026

Functional Strength Training and Kinesiotaping, With and Without Proprioceptive Neuromuscular Facilitation in Fibular (Peroneal) Neuropathy

An interventional study of Functional Strength Training, Kinesio Taping, and Proprioceptive Neuromuscular Facilitation and Functional Strength Training and Kinesio Taping in Peroneal Neuropathy, sponsored by University of Lahore. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-03-05.

Sponsored by University of Lahore · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

Fibular neuropathy frequently manifests as foot drop, muscle weakness, altered gait, and sensory loss, all of which severely reduce mobility and quality of life. There is still uncertainty regarding the efficacy of kinesio taping (KT), proprioceptive neuromuscular facilitation (PNF), and functional strength training (FST) in combination. Although PNF improves neuromuscular coordination, KT provides proprioceptive input, and FST increases strength and mobility, there are no set treatment guidelines and little research has compared these modalities. In order to contribute to evidence-based rehabilitation techniques for people with fibular neuropathy, this study attempts to assess whether adding PNF to FST and KT improves functional outcomes compared to FST and KT alone.

02

Conditions studied

  • Peroneal Neuropathy

Browse trials for

03

In context

Peroneal Neuropathies

41 studies on the registry are indexed under Peroneal Neuropathies; 9 are open to participants now.

This study's enrollment of 48 is above the median of 30 across 31 interventional studies indexed under Peroneal Neuropathies.

Browse Peroneal Neuropathies studies →

Lead sponsor

University of Lahore is the lead sponsor of 223 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

    • Adults (18-35 years old) are diagnosed with fibular neuropathy due to trauma or compression.

      • Patients with muscle weakness, impaired balance and abnormal gait.
      • Both Male and female participants will be included.
      • Patients who test positive to the drag or slap test will be considered positive if the patient have difficulty in lifting the forefoot while walking, leading to dragging of the toes or compensatory hip/knee movements.

Exclusion criteria

Exclusion Criteria:

    • Recent foot or ankle surgery (\<6 months).

      • Complete loss of nerve supply
      • Severe musculoskeletal or neurological conditions (Amyotrophic lateral sclerosis, multiple sclerosis, myopathies, severe osteoarthritis, severe compression, progressive neuropathies, severe balance and fall risk, Guillain-Barré Syndrome (GBS) and peripheral vascular diseases).
      • Allergies to Kinesio tape materials.
      • Patients who are not psychologically fit such as those who have undergone trauma and patients with severe psychological disorders (major depressive disorder, PTSD, schizophrenia) will be excluded if they have had a diagnosis within the last 6 months.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    Interventional Group A

    Functional Strength Training (FST) + Kinesio Taping (KT) with Proprioceptive Neuromuscular Facilitation (PNF).

    Behavioral: Functional Strength Training, Kinesio Taping, and Proprioceptive Neuromuscular Facilitation · Behavioral: Functional Strength Training and Kinesio Taping

  • Active comparator
    Control Group B

    Functional Strength Training (FST) + Kinesio Taping (KT) without PNF.

    Behavioral: Functional Strength Training, Kinesio Taping, and Proprioceptive Neuromuscular Facilitation · Behavioral: Functional Strength Training and Kinesio Taping

Interventions

  • BehavioralFunctional Strength Training, Kinesio Taping, and Proprioceptive Neuromuscular Facilitation

    Participants will undergo 8 weeks of supervised treatment, 3 sessions per week (24 sessions). Each session includes a warm-up with stretches, range-of-motion exercises, and Functional Strength Training (mini hops, stair climbing, ramp walking, sit-to-stand). Kinesio Taping will be applied from the foot's dorsum along the tibialis anterior and peroneus longus with 25-50% stretch for ankle support and dorsiflexor facilitation, re-applied every 3-4 days. In addition, Proprioceptive Neuromuscular Facilitation (PNF) lower-limb D1 flexion/extension patterns with manual resistance will be performed in 3 sets of 5 repetitions, lasting 35-40 minutes per session.

  • BehavioralFunctional Strength Training and Kinesio Taping

    Participants will undergo 8 weeks of supervised treatment, 3 sessions per week (24 sessions). Each session includes a warm-up with stretches, range-of-motion exercises, and Functional Strength Training (mini hops, stair climbing, ramp walking, sit-to-stand). Kinesio Taping will be applied from the foot's dorsum along the tibialis anterior and peroneus longus with 25-50% stretch for ankle support and dorsiflexor facilitation, re-applied every 3-4 days. No PNF techniques will be applied.

06

What researchers measure

Primary outcomes

  1. Change in dorsiflexor muscle strength measured by Manual Muscle Grading (MMG)

    Time frame: Baseline (Week 0), Mid-point (Week 4), and Post-intervention (Week 8)

07

Study locations

1 site
  • UIPT, UOL, Lahore
    Lahore, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07191301
Lead sponsor
University of Lahore
Responsible party
Sumayyah Farooq (Principle Investigator, University of Lahore) — Principal investigator
First posted
Sep 24, 2025
Start date
Aug 10, 2025
Primary completion
Dec 10, 2025
Completion
Dec 30, 2025
Last update
Mar 5, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion